Rapid sterility and bioburden testing are critical elements in pharmaceutical quality control, helping to guarantee product safety. Unlike traditional methods, which can be time-consuming and delay urgent therapies for patients, these rapid testing approaches employ innovative techniques such as solid-phase cytometry or growth-based methods to deliver swift and accurate results.

Imagine needing results within the same work shift. Enter the ultra-rapid SCANRDI^® method, a game-changer for pharmaceutical facilities. It not only sweeps away bottlenecks in the quality control lab but also empowers you with greater process control. With results available in under four hours, you can swiftly assess the integrity of vital manufacturing steps, such as bioburden monitoring and sterility testing.

And if you're seeking a method that's accessible and easy for anyone to use, look no further than the fully automated and user-friendly BACT/ALERT^® system. Based on more than 20 years of experience, it's designed to work seamlessly with complex matrices and can be employed for bioburden testing or final product release checks.

By adopting these proven rapid testing methods such as SCANRDI^® or BACT/ALERT^®, pharmaceutical companies can enhance efficiency, reduce production timelines, and maintain the integrity of their products. As a result, you can deliver critical therapies quickly and safely to the patients.

The integration of rapid sterility and bioburden testing in pharmaceutical quality control underscores a commitment to both excellence and patient well-being. As the industry continues to evolve, these rapid testing techniques stand as indispensable tools that enable us to provide timely, effective, and safe treatments to individuals worldwide.

Click here for more information about our rapid sterility testing solutions or use the green button below to contact us directly.